Clinical Trials Logo
  1. Home
  2. Bipolar Disorders
  3. NCT01188148

Series Studies of Bipolar Disorder-Valproate add-on Memantine — MM  

Bipolar Disorders Clinical Trial

Official title:
Series Studies of Bipolar Disorder-Valproate add-on Memantine Treatment

Clinical Trial Summary

All participants should fulfill the following criteria: aged between 18 and 65 years old, and of domestic Han descendants. Participants will be randomly assigned to either the (1) pharmacotherapy (valproate add-on memantine) group; (2) pharmacotherapy (valproate add-on memantine) plus Cognitive Behavior Group Therapy (CBGT) group; (3) valproate add-on placebo plus CBGT group, or (4) valproate add-on placebo only group. A total of 240-320 individuals (60-80 participants per group) will be recruited for this study. For each CBGT group, 12-weekly sessions are scheduled according to patients' preference. The investigators will attempt to understand the effects of pharmaceutical drugs for mood stabilizers add-on neuro-protective drugs, pharmacotherapy with CBGT, mood stabilizer with CBGT, and the use of only traditional mood stabilizers in the treatment of BP II. Comparisons will be made for each type of treatment and possible mechanisms will be examined regarding the pharmacotherapy and CBGT for bipolar disorder patients.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01188148
Study type Interventional
Source National Cheng-Kung University Hospital
Contact
Status Completed
Phase Phase 2/Phase 3
Start date August 2009
Completion date October 2012
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05537376 - A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness N/A
Completed NCT00240721 - A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder Phase 3
Completed NCT02242669 - Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders N/A
Completed NCT01821469 - Functional Correlates of Bipolar Disorders and Effects of the Psychoeducation. an fMRI Study N/A
Completed NCT00888264 - A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder N/A
Completed NCT02807688 - Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses N/A
Completed NCT00253162 - A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol Phase 3
Not yet recruiting NCT02904083 - Study of the Effectiveness of Specific Training of Health Professionals on Adherence in Bipolar Disorder N/A
Completed NCT01729650 - Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor) N/A
Recruiting NCT02843906 - Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection? N/A
Completed NCT01377896 - The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours N/A
Completed NCT00453804 - Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) Phase 4
Terminated NCT00047567 - Open-label Adjunctive Zonisamide for Bipolar Disorder Phase 4
Completed NCT03028545 - Representations and Strategies for Recovery N/A
Completed NCT00156325 - Escitalopram as a Mood Stabilizer for Bipolar II Disorder Phase 2
Completed NCT06034769 - Oral and Jaw Health in Bipolar Patients
Terminated NCT02936466 - Evaluation of a Serious Game for Patients With Bipolar Disorder Involved in a Psychoeducation Group N/A
Completed NCT00845988 - Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders Phase 4
Completed NCT00257075 - A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder Phase 3
Recruiting NCT01188395 - Bipolar Disorder With Alcoholism in Han Chinese N/A